
See
also Jim Adams journal in this site:
·
Overview of Autism
Research, Testing, and Treatments
· Literature Review of Essential Fatty
Acids
·
Summary of Montreal’s 3rd
Annual Medical Conference on Autism
By James Adams (parent)
jim.adams@asu.edu (comments welcome)
First, many thanks to Bernie Rimland, Maureen Odonnell, Sid Baker and Jon Pangborn for all their efforts in organizing the conference and the new DAN! Protocol. The new version of the DAN! Treatment protocol is available from the Autism Research Institute, 4182 Adams Ave, San Diego, CA 92116 for $20. It is authored by Jon Pangborn, Ph.D., and Sidney Baker, M.D. It is a major revision, and is now 161 pages.
Summary of Friday’s Advanced
Practitioner’s Session:
(There was also a new parent session and another
practitioner’s session)
Opioid
Peptides:
Karl Reichelt, Ph.D., presented a
summary of many years of work by himself and others on the role of opioid
peptides in autism. Protein is made of
peptides, which are made of amino acids.
Basically, his lab and several others have published many articles in
the scientific literature on their findings of unusual proteins and peptides in
the urine of people with autism. Those
proteins and peptides come from casein (dairy) and gluten (wheat and related
grains), and they have an opioid-like effect on the brain, with a potency
several times that of morphine. The
peptides enter the blood due to 2 major biological flaws: 1) a failure of the
digestive track to fully digest/break-down the casein and gluten molecules into
amino acids, and 2) a “leaky gut” which allows the undigested proteins/peptides
to pass into the blood stream. The
failure of the gut to properly digest the proteins is apparently due to a lack
of peptidases (digestive enzymes), which he hypothesizes could be due to
genetic defects (other speakers also discussed environmental and nutritional
causes). Recent work by Dr. Cade (1999)
found antibodies (IgA) to gluten and casein in the mucous membranes of 12 of 44
people with autism. These opioid
peptides can have many behavioral and physical effects, and could cause many of
the symptoms of autism.
A single-blind, 2-year study found that children with autism improved on a gluten-free, casein-free (GFCF) diet, but regressed if the diet was stopped. A recent 2001 study by Cade found that digestive enzymes helped, but were only half as effective as a GFCF diet. Currently, the best labs have about a 5-10% false negatives and positives, so he recommends everyone with autism try a GFCF diet.
Summary: Gluten and casein, from dairy and wheat, appear to have an
opioid-effect in autism, so a trial of total avoidance is strongly recommended.
Immunology – Dr. Gupta gave a very detailed talk on immunological
abnormalities in autism. Basically, the
immune system is composed of T cells (to fight viruses and fungi), B cells (to
fight bacteria), Natural Killer cells.
T cells consist of TH1 and TH2 cells.
In autism, there is a major shift from TH1 to TH2. The decrease in TH1 may explain the
increased susceptibility to viral and fungal infections in autism. The increase in TH2 may explain the
increased autoimmunity, such as his findings of antibodies to myelin basic
protein (MBP) and neuronal axonal filaments in the brain. Also, there is an increase in tumor necrosis
factor (TNF) in autism, which could lead to decreased blood flow into the
brain, a loss of Purkinje cells (often found on autopsy), alterations in
neurotransmitters and neuropeptides, and possibly demyelination, as found in
multiple sclerosis (MS). The decrease
in TH1 could explain the “leaky gut” in autism, due to more viruses causing the
lymphoid cells to multiply rapidly (as found by Dr. Wakefield in many cases),
and causing more peptide absorption (as found by Dr. Reichelt and others). Mercury could also play an important role,
as it can poison mitochondria (the part of every cell that produces energy),
and it can denature DNA, alter membrane permeability, induce autoimmunity, and
cause apoptosis (cell death). In a
test-tube, very low (micromolar) concentrations of thimerosoal were found to
cause cell death, and the addition of glutathione was found to block thimerosal
and reduce cell death. One possible
therapy for autism is intravenous Immunoglobulin, which can neutralize bacteria
and viruses and promote phagocytes to attack bacteria and fungi.
Summary: In autism, there is a major change in the immunological system, making people with autism vulnerable to bacteria, fungi, and viruses, and causes the immune system to attack the body (autoimmunity). Mercury is a possible cause of this.
Sulfation: Susan Owens substituted for Rosemarie
Waring, and presented Dr. Waring's data on sulfate in autism. Basically, people with autism were found to excrete
roughly twice as much sulfate in their urine, so that they had only 1/5 the
normal level of sulfate in their bodies.
Sulfur is an essential mineral, and is needed for many functions in the
body. AIDS patients have also been
found to exhibit a loss of sulfur in their urine, leading to a loss of
extracellular sulfated structures in the brain. This has not yet been investigated in autism, but may be the
same. In AIDS patients, treatment with
N-acetyl cysteine was found to be beneficial.
In autism, TNF (tumor necrosis factor) is elevated, which can
inhibit the conversion of cysteine to sulfate.
Low sulfur levels could
cause many problems.
· Sulfur is needed to sulfate
the hormone CCK, which stimulates oxytocinergic neurons to release
oxytocin. So, a lack of sulfur could
explain the low oxytocin levels found in autism, which is important for
socialization.
· Sulphate is important for
detoxification of metals and other toxins.
· Sulphation requires
activated sulfate, which requires magnesium.
· Boys excrete more sulfur
than girls, so they may be more susceptible to sulfation problems.
· Wakefield's group found that
the ileum of the intestine lacks sulfur, which would lead to a leaky gut.
· Sulphate is needed to
release pancreatic digestive enzymes.
· Many enzymes would be
impaired if sulfur levels were low.
· The perineuronal nets around
neurons, which modulate their function, are primarily composed of chondroitin
sulfur. Low sulfur would thus yield
less modulation of neurons
· The hepatitis B vaccine was
found to inhibit sulphation chemistry for one week in typical people.
Summary: Almost all people with autism have very low levels of sulfur in
their blood, which could cause many of the problems associated with
autism. Sulfur could be replaced by
Epsom salt baths, sulfate creams (now available from Kirkman labs), or possibly
with cysteine or n-acetyl cysteine (but Pangborn has concerns about the use of
cysteine or n-acetyl cysteine). Since
sulfate leaves the blood in 4-8 hours, it should be used at least 1x/day, and
possibly more often.
Mercury: Jim Laidler discussed
the latest statistics from the US Dept of Education on the number of people
with autism, which show a 10-fold increase in the number of people with autism
over the last 7 years. Also, they show
that, unlike other disabilities, the number of people with autism is heavily
skewed towards the younger ages (twice as many in the 6-11 as the 12-17 group).
Some similarities between autism and mercury toxicity include restriction of visual field (tunnel vision), autoimmune abnormalities, and many other symptoms.
Mercury detoxification is best done with DMSA. Chlorella and cilantro should be avoided because, although they gather mercury from the environment, they do not bind mercury as strongly as human tissue, so they will tent to release mercury into humans. DMSA can best be used on a 3 day on, 11 day off cycle, with dosing every 8 hours (4 hours vs. 8 does not seem to make much difference). DMSA may cause some fatigue or irritability, since it seems to cause GI dysbiosis temporarily. DMSA does not transport mercury into the brain. Once DMSA has lowered the level of heavy metals, alpha lipoic acid can be added on the days of DMSA, and will increase excretion of mercury. Doses for alpha lipoic acid can start at 1-3 mg/kg-day, and increase up to 10 mg/kg-day. Chelation should be stopped either when metal excretion is not detectable, or when no further improvements are observed. Since some people with autism improve on DMSA even when little metal is being excreted, DMSA may be having other effects, such as acting as a powerful antioxidant, removing cysteine, or binding to gliotoxin (a toxin from yeast that affects neurons).
He also discussed the possible connection between the NMDA (n-methyl d aspartate) receptor and autism. Blockage of that receptor could cause reduced pain, tunnel vision, inability to shift attention, auditory problems, repetitive behaviors, dilated pupils, and language problems. The reason is that it controls pruning of brain cells during development, modulates pain, and modulates dopamine and serotonin.
Summary: The increase in the number of people with autism could be
explained by mercury in vaccines. Many
symptoms of autism could be explained by mercury toxicity. DMSA, followed by DMSA and alpha lipoic
acid, are effective in decreasing mercury levels, and can improve the symptoms
of autism in some cases.
Lab Tests: Jon Pangborn discussed biochemical types of autism. These include:
·
PKU
variants: may involve
dihydrobipterin-to-tetrahydrobiopterin (DPR or DHR reductase)
i. Phenylalanine -> Tyrosine
ii. Tryptophan -> 5-HTP ->
Serotonin
·
Fragile
X: may involve deficiency of deoxyuridine to deoxythymidine transformation due
to 5,10 methylene THF dysfunction
·
Histidinemia: Histidine -> 5-Formimino THF
· Adenylosuccsinate Lyase
Deficiency
i.
Adenylosuccate
-> AMP + Fumarate
ii.
Purine
synthesis decreased before formation of inosine
·
5-PRPP
Synthesis Deficient: - initial and rate limiting step for purine synthesis;
5-PRPP also needed for pyrimidine synthesis
·
Inosine
Phosphate Dehydrogenase Weakness
i.
Inosine
phoshate -> guanine phosphate, which makes biopterin
·
Lesch-Nyhan
Disease
i.
Hypoxanthine
-> Inosine Phosphate
ii.
Increase
in uric acid and oxidants
·
Purine
autism – adenosine deaminase deficiency
·
DPPIV
weakness – adenosine deaminase binding protein (CD 26) – inability to digest
casein and gluten
For each of the disorders listed above, he provided a flow chart of how each of them can affect metabolism. He also listed specific lab tests for Hyperphenlyalaninemia / uria, Histidineemia, Fragile X, Rett, Lesch-Nyhan Syndrome, and Purine Autism.
He briefly discussed the
many factors that could weaken DPPIV, the enzyme need to digest gluten and
casein, and he mentioned an open (non-blinded) study of EnZymAid and how it
helped improve several symptoms of autism.
Finally, he gave examples of typical
findings in elemental analyses of packed red blood cells and hair, amino acid
testing, detox profiles, comprehensive digestive stool analyses, yeast
sensitivity, bacterial sensitivity, and fatty acid analysis. This is all discussed in more detail in the
new DAN! Protocol, which he co-authored.
Treatments: Woody McGinnis (from
Practitioner Training session 1):
Autism and ADHD are similar, with
multiple underlying problems, and the gut and nutrition are of paramount
importance. There has been extensive
reports in the literature of GI problems.
In particular, 85% of children suffering from night awakening were found
to have reflux esophagitis – stomach acid rose into their esophagus when they
lay down, burning it.
GI problems lead to poor
nutrient digestion and absorption, a leaky gut, microbial overgrowth, and
possibly altered signaling to the brain (80% of vagus nerves go from gut to
head).
Low zinc can lead to low
stomach acid, which is critical for digestion.
45% of people with ADHD have low stomach acid, and probably similar for
autism.
Greater oxidative stress is
common. Hence, give vitamins C, E, A,
zinc, selenium, and taurine. Both the
gut and brain are very sensitive to oxidative stress.
To help with detoxification,
give B6, B12, folate, Mg, zinc, selenium, lipoic acid, and methionine.
Possible treatments include:
diets (GFCF, low sugar, organic (esp. meat), purified water, no Nutrasweet),
digestive enzymes, probiotics, vitamin/mineral supplements (esp. zinc and C),
cod liver oil (for vitamin A and D), fish oil and evening primrose oil (for
omega 3 and omega 6 fatty acids), anti-viral medications, secretin, DMSA/alpha
lipoic acid (to remove heavy metals), and bethanecol (helps intestinal mucosa,
stimulates digestive enzymes).
Recommends full nutritional
assay. This includes checking stool pH
(easy at home), IgE or IgG food testing, and urinary pyroles (25% of autistics
have bad toxin; Vitamin Diagnostics is one possible lab).
For constipation problems,
recommends magnesium citrate, fiber, vitamin C, and bethanecol.
Glutamine can be great to
feed intestine, but avoid if blood ammonia high.
First, Jeff unveiled his
plans to create an integrated campus facility to treat the biological,
behavioral, and nutritional needs of people with autism. He hopes to raise $20-$30 million in private
funds to create it.
Then he began discussing the
biological problems in autism and how to treat them. First, he explained that vaccines and vaccine additives can shift
the immune system from TH1 to TH2. In some
cases these additives are added specifically to stimulate antibody production,
but in the case of autism it may overstimulate it, causing autoimmunity
problems.
Next, he discussed the
etiology of autism in the following series:
1)
autistic
enterocolitis creates an abnormal environment for bad bacteria, yeast, and
parasites
2)
Mercury
exposure alters the type of microorganisms in the gut (also occurs when DMSA is
used to excrete mercury)
3)
In
his small study, he found that on a DMSA challenge test, autistic children
excrete 5x as much mercury as normal children (8.63 mcg per 24 hr, vs. 1.48 mcg
per 24 hr). Thus, either they were
exposed to high amounts and/or they have a limited ability to excrete it. The mercury can have many effects, including
completely inhibiting the DPPIV, needed to digest gluten and casein.
4)
In
terms of nutritional abnormalities:
a.
Zn
deficiency exists in 90% of autistic children
b.
Cu
excess exists in 90%
c.
Calcium
and magnesium deficiencies are common
d.
Omega
3 deficiency exists in nearly 100%
e.
Fiber
deficiency exists in nearly 100%
f.
Antioxidant
deficiency exists in nearly 100%
5)
The
damaged GI tract causes poor protein digestion. This results in:
a.
Deficiency
of essential amino acids
b.
Extra
food for bad bacteria, causing high levels of ammonia (a toxin) – substances
that reduce ammonia may reduce brain fog (alpha keto glutaric acid is one
option)
c.
Gluten
and casein peptides, which act as opioids
d.
Undigested
proteins causing allergic reactions in gut and blood
He also listed treatment
options for various disorders. These
include:
Treatment for Viral
Infections:
Monolaurin: ¼ tsp., 3x/day: active vs.
measles, HHV-6, pathogenic bacteria; seemed to have helped 2 kids
Treatment for Weakened Immune
System
· Zinc: 20-200 mg
· Beta-glucan (activates
macrophages, the part of the blood that eats foreign matter)
· Caution: easily becomes rancid, so make sure you get
a good brand
· IP-6 (from Enzymatic
Therapy): activates Natural Killer cells; 1-2/day on empty stomach
· Transfer Factor: from
Chisolm
· Oral immune globulin –
prescription only
Treatment for Mercury and other Heavy Metals
(See Consensus Treatment for Metal Detoxification
for Children with Autism)
· DMSA:
but it can cause temporary regression, possibly by the undigested amount
feeding gut bacteria
·
Alpha
Lipoic Acid: but caution, it can make some children worse
·
Glutathione: oral, transdermal, or intravenous
·
Colostrums
(Kirkman's Super Colostrum Gold)
·
Monolaurin
·
Vancomycin
or flagyl – to fight bad bacteria
·
Fiber (Miralax is one option)
·
Reduce
sugars
·
Eat
vegetables
·
Essential
fatty acids
Treatment for Protein
Maldigestion:
·
morselation: chew food into smaller pieces, so more
surface area for digestion
·
Digestive
Enzymes: options include EnzymAid,
Creon, others for all meals/snacks
Treatment for Ammonia Excess
·
It
is a neurotoxin. To test for it, ship
blood only on dry ice.
·
To
treat it, follow treatment for protein maldigestion. Also, reduce/eliminate glutamine. Finally, use alpha keto glutaric acid, 100-300 mg, 2x/day
Treatment for Nutritional Deficiencies
·
Essential
fatty acids
·
High-quality
food (no junk food, soda, etc)
·
Eat
smaller portions, more frequently
Treatment for Food Allergies
·
Rotation
diet (don’t eat the same thing)
·
Digestive
enzymes
·
IV
Immunoglobulin and mercury detoxification may help
Treatment for Detoxification:
·
Transdermal
magnesium sulfate (Kirkman), Epsom salt baths
·
Glutathione
– transdermal or IV
·
Milk
Thistle – to support liver
Summary:
1)
gut
damage creates breeding ground for bad bacteria and fungi
2)
mercury
causes GI problems
3)
many
nutritional deficiencies exist
4)
poor
protein digestion causes nutritional deficiencies and food for bad bacteria
Effective treatments for the above conditions exist
and can help.
Also, at the meeting Kirkman
Laboratories distributed a free 176 page Guide to Intestinal Health in Autism
Spectrum Disorder. You can request a
copy from Kirkman Labs, 1-888-KIRKMAN.
Day 2:
Yeast Treatments: Sidney
Baker:
Dr. Baker discussed the
importance of first evaluating the severity of each symptom on a simple scale
(3=mild, 6=moderate, 9=severe, 12=incapacitating), and then trying different
treatments and evaluating their effect.
Ie, treat the child, not the tests.
He mentioned GFCF diets,
anti-fungal treatments, vitamin/mineral supplements, and essential fatty acid
supplements.
He especially discussed an unusual
anti-fungal treatment, saccharomyces boulardi (available from 1-800-426-2831),
which is a yeast that attacks other yeast.
It produces lactic acid that promotes good flora. As with any effective anti-fungal, it can
cause a die-off reaction (when the yeast die all their toxins are released at
once), and activated charcoal (from a pharmacy, 4x/day) can help absorb those
toxins. He also listed several nonprescription anti-fungal treatments,
including capryllic acid, undecelynic acid, citrus seed extract, oil of
oregano, and garlic. Both organic acid
tests and stool tests can sometimes be contradictory and misleading.
He mentioned that high methylmalonic acid
is an indicator of vitamin B12 deficiency, and recommends B12 injections in
those cases (absorption of B12 is very low in the digestive tract). Only Vitamin Diagnostics has a good direct
test for B12 test. B12 injections can
help within hours to days.
Secretin –
Walter Herlihy
(RepliGen)
Initial collection of
parental reports by the Autism Research Institute (Bernie Rimland) helped them
determine that a single infusion of secretin seemed to help for 3-5 weeks.
In order to win FDA approval
for secretin, there are three phases of testing. For secretin, Phase 1 (safety) and Phase 2 (establish dosing)
have been completed. They are now hoping
to start Phase 3 (statistical proof of efficacy).
In reviewing the Phase 1
trials, most of them were small, so that although they showed some improvement
the results were not statistically significant. However, pooling all of the results into a meta-analysis did show
a positive benefit of secretin.
In the phase 2 trials, 126
patients at 5 labs were involved in a double-blind, placebo-controlled study
including 3 infusions. The results of
the two standardized tests (GARS and CARS) showed only minor improvement, and
were not statistically significant.
Clinical Global Impressions (CGI, a very simple 1-7 scale rating whether
they became better or worse) was rated by parents and by professionals. The parents results showed a 0.43
improvement on the scale compared to controls, which was statistically
significant, but the professionals found only a 0.22 improvement, which was not
statistically significant. The ADOS
test, which has become the gold standard for assessing severity of autism,
found some improvement, but again not statistically significant. The MacArthur Language Inventory found a
small effect of secretin, but it was not statistically significant. Finally, there was an evaluation of GI
function, but there was no difference between the children who received the
placebo vs. the secretin.
However, analysis of stool
samples found that many of the children had abnormal levels of chymotrypsin
(29% had low levels) or calprotectin (26% had elevated levels). These abnormalities seemed to result in more
day-to-day variation in behavior, and made it harder to evaluate. So, the data was re-analyzed without those
children, leaving 64 children to be analyzed.
Those results were more positive, and statistically significant results
were found in the data was then re-analyzed to only count children who did not
have chymotrypsin or calprotectin abnormalities in the stool, as those seemed
to cause a lot of day-to-day variation in behavior. In this case, the CGI-parent and CGI-professional scores, the
ADOS, and the MacArthur Language Inventory all showed statistically significant
results.
In addition, his lab
searched for opioid peptides, but did not find any in the 120 patients that
they investigated, which is a curious contradiction with work by Reichelt,
Cade, Shattock, and several other researchers who have found them.
Conclusion: The phase II study showed some statistically significant benefit
for secretin, especially when considering only the subset of children who did
not have chymotrypsin or calprotectin abnormalities. The benefits included language, but did not include GI function.
Disordered
Metal Metabolism: William Walsh first
discussed his data on 503 children with autism, which found an elevated Cu:
Zinc ratio in nearly all the children.
Specifically, 85% had very high Cu: Zinc ratios, 8% were receiving zinc
supplements and had only moderate imbalances, 6% has a severe pyrole disorder
(indicating severe zinc depletion), and only 4 of the 503 children did not have
a serious Cu: Zinc imbalance. The average
Cu: Zinc ration was 1.63 in autism, vs. 1.15 in the controls, and was highly
statistically significant (p<0.0001).
This is a very important finding from a very large study.
Walsh hypothesizes that the
Cu: Zinc imbalance could be due to a defect in metallothionein function, since
metallothionein proteins regulate Cu and Zinc levels. The primary functions of metallothionein include: development of
brain neurons; cell transcription; regulation of Cu and Zinc; detoxification of
heavy metals; maturation of GI tract; powerful antioxidant; immune function;
deliver of zinc to cells. It is the
primary defense of the body against heavy metals. If a defect in metallothionein exists, it could be due to a
genetic impairment or due to environmental damage.
There are four
metallothionein proteins:
MT-I and MT-2 are present in
all cells throughout the brain and periphery
MT-III is a neuronal growth
inhibitor found primarily in brain
MT-IV is found primarily in
skin and GI tract.
A defective metallothionein
could explain many of the symptoms of autism, including sensitivity to heavy
metals, zinc depletion and copper overload, reduced stomach acid, incomplete
breakdown of proteins. Since
metallothionein production is enhanced by estrogen and progesterone during early
development, females will be better protected than males against heavy
metals.
Researchers studied a
MT-knockout mouse (a mouse without any metallothionein) and found that it had a
very weakened immune system and had a high incidence of seizures.
The activity of
metallothionein is primarily enhanced by zinc, glutathione, selenium, and
n-acetyl cysteine. Of secondary benefit
are vitamins B6, A, C, D, E, genistein, biochanin A, and glucorticoids.
In Wilson's disease, copper
overload can be treated by removing excess copper and long-term zinc
therapy. This may also help in autism,
and may lead to reduced GI problems, improved behavior and cognition, and
reduced vulnerability to heavy metals.
His lab (Pfeiffer Labs) is investigating nutritional interventions to
promote metallothionein and thereby reduce symptoms of autism.
However, there are no
commercial lab tests for metallothionein, and the children with autism did not
have their metallothionein levels tested.
Also, their lab found that
45% of children with autism were undermethylated (needed folate and DMAE),
whereas 15% were overmethylated.
Conclusion: In a very large and important study of 503 children with autism,
a very high Cu: Zinc ratio was found.
This could have a wide-reaching effect since copper and zinc play many
roles in the body. It is hypothesized
that the Cu: Zn imbalance is due to a defect in metallothionein, and such a
defect could explain many of the biochemical abnormalities in autism. Nutritional interventions with zinc and
other supplements are recommended for treating this imbalance.
Paul Shattock (AKA Robert
Redbird):
Paul humorously discussed the great increase in the incidence of autism, which now affects 1 in 150 children. He thinks it is due to a combination of a genetic susceptibility and an increase in an environmental toxin(s). These could include vaccines, pesticides, dietary changes, gut dysbioses, heavy metals, plasticizers, toxic fumes, food additives, and drug residues in food and water.
In his studies of the urine
of people with autism, they often find peptides that are similar to opioids,
several times as potent as morphine.
Opioids are known to decrease sociability, decrease memory and learning
ability, increase stereotopy and hyperactivity, cause constipation and lower
body temperature. These peptides could
interfere with the central nervous system, and affect many functions, including
perception, cognition, behaviors, mood, emotions, CNS development, immune system,
and gut function.
Based on the levels of one
type of peptide (IAG), there seem to be two types of autism:
Type 1: elevation in many
peptides, including IAG
Type 2: elevation in many
peptides, but normal IAG
Type 2 is the more recent
type, and occurs about 10% of the time in the UK and 50% in the US, suggesting
it is due to vaccine exposure which is more recent and higher in the US. Type 2 children tend to be more social, have
unusual thirst, have an abnormal gait, and have bowel problems.
Elevated IAG levels are also
found in Gulf War veterans.
Freeman had found
dermorphin, a peptide 2000x more potent than morphine, in some children with
autism.
Waring had found that people
with autism had only 1/5 as much sulfur in their blood as normal, which could
cause several problems, including:
1)
neurotransmitters
not being processed after use
2)
reduced
ability to eliminate metals
3)
leaky
gut
4)
proliferation
of yeast in gut
Organophosphate pesticides
act by blocking enzymes in insects, and may also affect enzymes in humans and
IAG levels.
Sunderland treatment protocol (available at www.osiris.sunderland.ac.uk/autism)
1)
test
for celiac disease and amino acids
2)
vitamin/mineral
supplements
3)
GFCF
diet, and keep a food diary to determine if other foods should be avoided
4)
Test
vitamin/mineral levels, and test for allergies
5)
Comprehensive
digestive stool analysis
6)
Increase
sulfation with Epsom salts
7)
Try
betaine HCl to increase stomach acid
8)
Fatty
acid supplements
9)
L-glutamine
to feed intestinal mucosa
10)
5-HTP
11)
possibly
try chelation
Summary: There are elevated peptides in the urine of people with autism
that have an opioid effect, and could cause many of the symptoms of autism.
The US Dept of Education now
estimates that 1 in 150 children in the US have autism. This increase could be due to the increased
use of vaccinations. Vaccines contain
mercury (a preservative), aluminum (to increase antibody production), crude
toxoids, and live viruses. Prof. Singh
has found antibodies to myelin basic protein in many autistic children, and
this is likely related to an atypical measles infection.
He has tested the mercury
excretion of 200 children with autism using DMSA, and found that it varies
greatly with age, peaking around age 5 and again around age 10.
In collaboration with
researchers in Indonesia, a study of 27 children with autism found that 23/27
had autoimmunity, 6 of 27 had elevated mercury, and 25 of 27 had elevated mercury
in their hair.
Elevated ammonia is common
in autism, and a study of 65 children with autism found that 70% had levels
above the reference range of the lab.
Thrombophilia, a coagulation
disorder, was found in 70% of the children with autism, and in many of the
parents (he advised all parents to have it tested)
Day 1 Summary:
Ken Bock
provided a summary of what was covered on Day 1.
Day 2: Bernard
Rimland
gave an overview of the history of the fight against autism. He provided several articles on the
importance of B6 and magnesium, and discussed the effectiveness of DMG in
enhancing the immune system. He
discussed his survey results of thousands of parents on treatment efficacy (see
www.ari.org for full report).
Nutritional supplements 40-67% 0-7%
Special diets 41-52% 1-2%
Psychiatric medications 16-46% 15-47%
Supplements included
calcium, DMG, folic acid, melatonin, vitamin B3, vitamin B6 with magnesium,
vitamin C, and zinc.
Diets included candida,
Feingold, rotation, no chocolate, no dairy, no eggs, no sugar, no wheat.
Antifungal medications
included nystatin and diflucan.
Summary: Nutritional supplements, special diets, and antifungal
medications have been reported by parents to be beneficial in roughly half the
cases, with minimal risk of becoming worse.
Omega 3 Fatty
Acids: Andrew Stolle:
Omega 3 fatty acids have
been evaluated for the treatment of a wide range of psychiatric disorders,
including schizophrenia, depression, postpartum depression, and bipolar
disorder. DHA (found in flaxseed) does
not help those conditions, but EPA (found in fish oil) does help. In fact, EPA was often more beneficial than
conventional medications.
In his previous study of
bipolar disorder, he found that 10 g/day of fish oil helped.
Eskimos consume 15-19 g/day
of omega 3 fatty acids (EPA and DHA), but in the US we consume less than 1
g/day, probably far less than is needed.
Omega 3 oils are created only by phytoplankton (algae), and are then
consumed by fish. Animals cannot make
omega 3 oils. The primary sources of
omega 3 oils are flaxseed (which has some drawbacks), seaweed (which may be
contaminated), fish oil, and Country Hen eggs (chickens fed flaxseed and fish,
so the eggs are high in omega 3).
In Japan, although they
consume a large amount of fish, they do not seem to be affected by the high
level of mercury in their diet.
Most commercial fish oils
are low quality. Need one that does not
have a rancid flavor. One option is
Omega Brite, which is highly concentrated.
There has been a theoretical
concern that too much omega 3 could cause bleeding, but studies of over 15,000
patients taking omega 3 found that there was no evidence of increased bleeding.
Dose: He recommends 2-5 g of omega 3, 1-2x/day,
with the EPA level much higher than the DHA level (except possibly for young
children, who need some DHA for their brain development, since the brain in 60%
DHA.
For more information, read
his book, The Omega 3 Connection.
Summary: EPA has recently proven to be beneficial in
a number of psychiatric disorders, whereas DHA has not. There has not been any formal research on
its use in autism, but it may be beneficial.
High-quality fish oil is a good source of omega 3 fatty acids.
Omega 3 Fatty
Acids: Paul Hardy
Dr. Hardy discussed his
experience with treating many people with autism with omega 3 fatty acids and
other nutritional supplements. He
hypothesizes that some people diagnosed with ASD may actually have bipolar
disorder.
During the last 100 years,
brain size has decreased 10%, and this could be due to a lack of omega 3 fatty
acids since they make up over 60% of the brain. Dietary intake of omega 3 fatty acids has greatly decreased in
the US. Farm-raised fish are usually
raised on corn, so they have little or no omega 3 fatty acids (which are made
by algae). Also, the use of cod liver
oil as a medication was largely stopped in the 1960s for no apparent
reason. Finally, baby formulas do not
contain any essential fatty acids.
In his clinical experience,
he finds that many people with autism have an omega 3 deficiency, and often
have elevated arachidonic acid (a bad fatty acid). Also, since omega 3 levels are very low in the US, the reference
ranges of the testing labs may be too low.
He estimates that 90% of people with ASD need omega 3 fatty acids.
He recommends 2-5 g/day of
combined EPA and DHA, starting at a lower level and increasing.
(All her viewgraphs are on
the www.ari.org website; she also recommends
going to www.safeminds.org)
She recommends a new book,
What Your Doctor May Not Tell You About Children's Vaccinations, by Stephanie
Cave (just released).
Hypothesis: In genetically susceptible individuals,
prenatal and early childhood exposure to mercury may cause neurological damage
leading to autism. This hypothesis is
supported by symptom comparisons, toxicity studies, case studies, and
epidemiology. The most likely sources
of the mercury are maternal dental fillings, maternal fish consumption,
consumer products (eye drops, nasal sprays, others), Rho-gam shot, Influenza
vaccine during pregnancy, and childhood vaccines. The increase in autism appears to correlate with the increased
use of vaccinations. In children who
are fully vaccinated, by the sixth month of life they have received more
mercury from vaccines than recommended by the EPA.
There are many similarities
in symptoms between mercury toxicity and autism, including social deficits,
language deficits, repetitive behaviors, sensory abnormalities, cognition
deficits, movement disorders, and behavioral problems. There are also similarities in physical
symptoms, including biochemical, gastrointestinal, muscle tone, neurochemistry,
neurophysiology, EEG measurements, and immune system/autoimmunity.
In an analysis of the
Vaccine Safety Database (two HMOs, covering 110,000 children born from 1992 to
1997), found that there were statistically significant associations between
cumulative exposure to thimerosal-containing vaccines and risk for developmental
delays, tics, ADD, language/speech delay and neurodevelopmental delay. However, there were too few children to
determine if there was a risk for autism.
Conclusion: Mercury may be the cause of some of the cases of autism. Children were exposed to high amounts of
mercury through childhood vaccinations, and there is a strong similarity in
symptoms between mercury toxicity and autism.
Dr. Holmes discussed the
treatment of mercury toxicity with DMSA, followed by DMSA plus alpha lipoic
acid. It is very difficult to test for
mercury toxicity, because it clears quickly from blood, urine and hair (within
months or less) and resides in tissue.
Instead, she recommends testing for the effects of mercury, including
urine organic acid, fractionated urine porphyrins, immune system test, and
other blood tests. She especially
favors looking for sulfate wasting in urine, as that indicates kidney
dysfunction, and mercury binds strongly to kidneys. (Note that Waring has found sulfate wasting in most children with
autism).
Before beginning mercury
detoxification, first clear up the gut of bacteria and yeast, and keep it
clean. Also, remove all sources of
mercury, including removing dental mercury-silver fillings, stop seafood
consumption, and avoid thimerosal exposure from vaccines or other sources. Also, nutritional supplements are important.
Then, in step 1, use DMSA
alone to remove mercury from the body.
Take a maximum dose of 10 mg/kg, 3x/day, for 3 days, then 11 days
off. Repeat several times. Glycine can be added, but has only a very
small effect on mercury excretion (5%).
Test urine after 2-5 rounds, since the metals are mostly excreted in the
urine. Continue until little
mercury/heavy metals are being eliminated.
Then, in step 2, take the
DMSA with alpha lipoic acid, at a ratio of DMSA: LA from 2:1 to 6:1. Whereas DMSA cannot cross the blood-brain
barrier, LA can, and causes the mercury to mostly be excreted in the stool. Thus, the addition of LA will result in much
more mercury being excreted, possibly from the brain. Test the stool every 4-6 months, to determine how much is
eliminated, and continue until it is in the normal range. If stool is difficult to obtain, hair can be
used instead.
Step 2 was greatly slowed if
lead or tin were still present, so it is important to remove those before
adding the LA to the DMSA.
During step 2, common side
effects are: worse behavior initially, diarrhea, headache, fatigue, overgrowth
of intestinal yeast and bad bacteria.
Also, must monitor complete blood counts, liver enzymes, and mineral
problems. These are uncommon effects,
affecting only 0.5%
She summarized their
preliminary results for treating 152 children with DMSA + LA after 6
months. Note that some children,
probably the older ones, might need longer treatment times.
Child’s age Level of Improvement
Marked Moderate Slight None
1-5 yr. 36% 39% 15% 9%
6-12 15% 35% 36% 15%
13-17 0% 17% 54% 29%
18+ 0% 14% 14% 71%
Marked improvement means
little/no autistic symptoms. The degree
of improvement correlated with the amount of metals being excreted on DMSA +
LA. The children who responded most
quickly were the ones who had developed normally and then regressed. The other children may take longer. Much more research is needed.
Conclusion: DMSA followed by DMSA + alpha lipoic acid is effective in
removing mercury and other heavy metals, and results in significant
improvements, especially in younger children and in those who had developed
normally and then regressed.
Dr. Wakefield first
summarized his research on autistic enterocolitis. First, there is evidence of a persistent viral infection in the
blood of many children with autism, based on decreased CD3 lymphocytes, raised
IgG1, and low IgG4 and IgG2. Also,
biopsies of children with autism reveals inflammation of the gut, including the
epithelium (lining), usually throughout the entire small intestine, large
intestine, and colon. Live measles
virus was found in 76 of 83 children with autism, vs. 1 of 35 controls. Genetic testing revealed that it was from
the vaccine strain, not the wild strain.
Dr. Singh tested autistic children and found that they tended to have
elevated levels of antibodies to measles, but not to other viruses. Altogether, this data suggests that MMR
could be causally related to autism.
To test that hypothesis, he considered a
challenge/re-challenge study.
Basically, he looked at children with autism who seemed to have
regressed after their first MMR. He
then followed the children to see what happened if they had a second MMR, and
compared them against children who did not have a second MMR. He looked at a wide range of types of data,
including behavior, physical symptoms, macroscopic and microscopic pathology,
and growth charts. In those children
who had a second MMR, over half of them had a second regression shortly after
that MMR, whereas few/none of the children without a second MMR had additional
regression. This appears to be strong
evidence that the MMR can cause autism.
At the end of the
conference, there was a Q&A period for the mercury panel, and then Sidney
Baker summarized what we had learned.
Overall, it was clear that many of the physicians and researchers agreed
on many points, although sometimes with different emphases.
------ || ------
See
also Jim Adams journal in this site:
·
Overview of Autism
Research, Testing, and Treatments
·
Literature
Review of Essential Fatty Acids
·
Summary of Montreal’s 3rd
Annual Medical Conference on Autism
| english version | contact us | tell your
friend | search |
![]()
Your interaction with this site to follow our site policy
Puterakembara ® 2003